Upgrade to SI Premium - Free Trial

Teladoc (TDOC) PT Lowered to $47 at Chardan Capital Markets, Keeps 'Buy'

February 28, 2018 7:29 AM
Chardan Capital Markets lowered its price target on Teladoc (NYSE: TDOC) to $47.00 (from $48.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles